X4 Pharmaceuticals Inc
NASDAQ:XFOR
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
X4 Pharmaceuticals Inc
NASDAQ:XFOR
|
US |
|
P
|
Publicis Groupe SA
DUS:PU4
|
FR |
|
I
|
Istyle Inc
F:IY5
|
JP |
|
L
|
Lam Research Corp
F:LAR0
|
US |
|
C
|
CardioComm Solutions Inc
XTSX:EKG
|
CA |
|
NetEase Inc
NASDAQ:NTES
|
CN |
|
Kingfa Science and Technology (India) Ltd
NSE:KINGFA
|
IN |
|
H
|
Huangshan Novel Co Ltd
SZSE:002014
|
CN |
|
S
|
Steelcase Inc
SWB:GJB
|
US |
|
Kerry Group PLC
ISEQ:KRZ
|
IE |
|
Bumi Resources Minerals Tbk PT
F:BUR
|
ID |
|
M
|
Micron Technology Inc
F:MTE
|
US |
|
Angel Yeast Co Ltd
SSE:600298
|
CN |
|
BACHEM HOLDING AG
SIX:BANB
|
CH |
|
Borders and Southern Petroleum PLC
LSE:BOR
|
UK |
|
H
|
Hurxley Corp
TSE:7561
|
JP |
|
D
|
Deutsche Telekom AG
SWB:DTE
|
DE |
|
Eastern International Ltd
NASDAQ:ELOG
|
CN |
|
UniCredit SpA
MIL:UCG
|
IT |
Bankruptcy Probability
X4 Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
X4 Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
X4 Pharmaceuticals Inc
NASDAQ:XFOR
|
295.1m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
509.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
249B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
208B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
137.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
96.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
96.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
52.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
38.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
X4 Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, X4 Pharmaceuticals Inc has total debt of 76.8m USD. This includes both short-term (0 USD) and long-term (76.8m USD) debt.
You can find a full breakdown on its Balance Sheet.
